$NXTC

$5.72 +$0.49 (9.38%) Close

$NXTC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NXTC Management Team

Dr. David Kabakoff

Independent Chairman of the Board

Age 77

Compensation $111.3K USD

Sex Male

Mr. Michael Richman

President

Chief Executive Officer

Director

Age 64

Compensation $1.511M USD

Sex Male

Mr. Steven Cobourn

Chief Financial Officer

Age 62

Compensation $993.3K USD

Sex Male

Dr. Timothy Mayer

Chief Operating Officer

Age 61

Compensation $872.2K USD

Sex Male

Mr. Kevin Shaw

Senior Vice President

General Counsel

Age 51

Compensation -

Sex Male

Dr. Sourav Kundu

Senior Vice President - Development and Manufacturing

Age 65

Compensation -

Sex Male

Dr. Solomon Langermann

Chief Scientific Officer

Age 65

Compensation $882.8K USD

Sex Male

Dr. Udayan Guha

Chief Medical Officer

Age 53

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. David Kabakoff Independent Chairman of the Board	77	$111.3K USD	Male
Mr. Michael Richman President Chief Executive Officer Director	64	$1.511M USD	Male
Mr. Steven Cobourn Chief Financial Officer	62	$993.3K USD	Male
Dr. Timothy Mayer Chief Operating Officer	61	$872.2K USD	Male
Mr. Kevin Shaw Senior Vice President General Counsel	51	-	Male
Dr. Sourav Kundu Senior Vice President - Development and Manufacturing	65	-	Male
Dr. Solomon Langermann Chief Scientific Officer	65	$882.8K USD	Male
Dr. Udayan Guha Chief Medical Officer	53	-	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

8.0 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Anne Borgman	58	2021 5 years	Independent	Nominating and Corporate Governance Committee	Curis, Inc.	$50,521
John G. Houston	66	2020 6 years	Independent	Compensation Committee · Chair	Arvinas Inc.	Not stated
Elaine V. Jones	71	2015 11 years	Independent	Nominating and Corporate Governance Committee · Chair	CytomX Therapeutics, Inc.	Not stated
Ellen G. Feigal	71	2021 5 years	Independent	Compensation Committee	Xencor, Inc.	$51,521
David Kabakoff	78	2015 11 years	Independent	Audit Committee	None stated	Not stated
Michael Richman CEO	65	2015 11 years	Not independent	None stated	None stated	Paid as CEO
Stephen W. Webster	65	2019 7 years	Independent	Audit Committee · Chair	Cullinan Therapeutics, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$NXTC Management Team

Dr. David Kabakoff

Mr. Michael Richman

Mr. Steven Cobourn

Dr. Timothy Mayer

Mr. Kevin Shaw

Dr. Sourav Kundu

Dr. Solomon Langermann

Dr. Udayan Guha

Board of Directors

Related-party transactions

No related-party transactions disclosed